SynthesisBritish journal of anaesthesia2026
Identifying predictors of neuropathic pain medication prescribing, adherence, and discontinuation: a systematic review and meta-analysis.
Synthesis in British journal of anaesthesia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- How the Reclassification of Gabapentinoids Reshaped Neuropathic Pain Treatment in Saudi Arabia: A Survey of Healthcare Professionals.Pain and therapy · 2026Article
- Long-Term Efficacy and Safety of Treatments for Chronic Peripheral Neuropathic Pain: A Systematic Review and Narrative Synthesis.Pain and therapy · 2026Review
- Burden and Treatment Preference of Probable Neuropathic Pain in 13 592 people: A Cross-Sectional and Discrete Choice Experiment in the General Population in Malaysia.Journal of the peripheral nervous system : JPNS · 2026Article
- A comparative analysis of clinical quality and readability of neuropathic pain patient information leaflets: Türkiye versus the United States.Turkish journal of medical sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPharmacoepidemiological studies show that large proportions of people with neuropathic pain are not prescribed the recommended medications, do not adhere well to these medications, and often discontinue the treatment within 6 months. Identifying what predicts these outcomes can inform a strategy to ensure that people with neuropathic pain are prescribed recommended medication and continue their treatment when appropriate.
methodsWe carried out a systematic review and meta-analysis to identify predictors of pain medication prescribing, adherence, and discontinuation in adults with neuropathic pain. Electronic searches were conducted in Embase, PubMed, Web of Science, and CINAHL Plus.
resultsWe identified 69 relevant studies and divided them into non-mutually exclusive categories based on the outcomes they had investigated. There were 53 studies on prescribing, 14 on adherence, and 27 on discontinuation. Predictors associated with being prescribed recommended neuropathic pain medications included having a mental health disorder, diabetes mellitus, and White race. Predictors associated with better adherence included being prescribed serotonin-norepinephrine reuptake inhibitors compared with gabapentinoids or tricyclic antidepressants, dose titration, and implementing a medicine reminder. Predictors associated with a higher likelihood of discontinuation included being prescribed tricyclic antidepressants rather than other antidepressants and having a combination of neuropathic pain medications rather than monopharmacotherapy.
conclusionsThere is a need to focus on improving neuropathic pain medication prescribing for ethnic minorities and people without diabetes mellitus. Adherence can be improved by using dose titration and medicine reminders. Prescribing monopharmacotherapy rather than combination pharmacotherapy for neuropathic pain could result in better treatment persistence. SYSTEMATIC REVIEW PROTOCOL: PROSPERO (CRD42023464307).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.